UBC Faculty Research and Publications

The Answer : Thiazides First-line for Hypertension Therapeutics Initiative (University of British Columbia)

Description

Therapeutics Letter 47 reviews first-line treatments for hypertension. Conclusions: Total mortality, coronary heart disease and end-stage renal disease are similar for first-line thiazides, CCBs and ACEIs. Heart failure is increased with first-line CCBs as compared to thiazides or ACEIs. Stroke is reduced with first-line thiazides as compared to ACEIs. BP control and tolerability are better with first-line thiazides as compared to ACEIs. Cost is substantially less for thiazides as compared to beta-blockers, ACEIs, CCBs, alpha blockers, and angiotensin receptor blockers.

Item Citations and Data

Rights

Attribution-NonCommercial-NoDerivatives 4.0 International